 surviv patient massiv lymphadenopathi prostat cancer evid heterogen tumour behaviour surviv patient prostat cancer detect lymph node enlarg period tomographi patient symptom sign biochem result lymphat spread pelvic abdomin node mass patient mass cm maximum node diamet cm two-third patient tumour stage treatment actuari surviv patient nodal enlarg year group surviv patient lymphadenopathi neg bone scan diagnosi patient node bone diseas vs year improv appar inabl certain tumour seed bone mark sensit node hormon manipul primari tumour grade similar group patient combin diseas complet remiss treatment reason heterogen biolog behaviour unclear observ import vigor treatment patient advanc lymph node diseas